Tissue repair and ulcer/wound healing - Institut Pasteur Euroconference: molecular mechanisms, therapeutic targets and future directions

IDrugs. 2005 May;8(5):381-3.
No abstract available

Publication types

  • Congress

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Cicatrix / drug therapy*
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Drug Delivery Systems / methods
  • Drug Delivery Systems / trends
  • Genetic Therapy / methods
  • Humans
  • Inflammatory Bowel Diseases / drug therapy
  • Inflammatory Bowel Diseases / immunology
  • Infliximab
  • Integrin alpha4beta1 / therapeutic use
  • Interferon-gamma / therapeutic use
  • Natalizumab
  • Nerve Growth Factor / genetics
  • Nerve Growth Factor / therapeutic use
  • Rats
  • Sheep
  • Stomach Ulcer / drug therapy*
  • Stomach Ulcer / therapy
  • Wound Healing / drug effects*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Integrin alpha4beta1
  • Natalizumab
  • fontolizumab
  • Interferon-gamma
  • Nerve Growth Factor
  • Infliximab
  • visilizumab